rucaparib

Clovis' Rubraca leads to 44% ORR in Phase II for CRPC
BioCentury
Sat, 10/20/18 - 11:07 pm
Clovis Oncology
Rubraca
rucaparib
metastatic castration-resistant prostate cancer
Is Clovis Oncology A Takeover Candidate?
Seeking Alpha
Mon, 06/26/17 - 04:54 pm
Clovis Oncology
M&A
rucaparib
PARP inhibitors
Clovis Oncology Secures FDA Approval for New Ovarian Cancer Drug
TheStreet.com
Mon, 12/19/16 - 11:51 am
Clovis Oncology
FDA
PARP inhibitors
rucaparib
ovarian cancer
Rubraca
3 Cancer Drugs That Could Get an FDA OK Next Year
Motley Fool
Mon, 10/10/16 - 09:02 am
FDA
rucaparib
Clovis Oncology
ovarian cancer
binimetinib
Array Biopharma
melanoma
brigatinib
Ariad Pharmaceuticals
non-small cell lung cancer
Clovis Falls on Fears Ovarian Cancer Drug Inferior to Competition
TheStreet.com
Fri, 10/7/16 - 04:55 pm
Clovis Oncology
ovarian cancer
rucaparib
Lynparza
AstraZeneca
Clovis soars on FDA decision to bypass panel for cancer candidate
Fierce Biotech
Fri, 09/9/16 - 10:24 am
Clovis Oncology
FDA
advisory panels
rucaparib
ovarian cancer
Clovis Jumps as Cancer Drug Gets Priority for FDA Review
Bloomberg
Tue, 08/23/16 - 05:47 pm
Clovis Oncology
FDA
priority review
rucaparib
ovarian cancer
Clovis Oncology Presents Data from Phase 2 Studies of Rucaparib in Advanced Ovarian Cancer and Pancreatic Cancer at 2016 ASCO Annual Meeting
Yahoo
Mon, 06/6/16 - 11:04 am
Clovis Oncology
rucaparib
ovarian cancer
pancreatic cancer
ASCO 2016
Biotech Clovis Oncology raising $275 million for new cancer drugs
Bizjournals.com
Wed, 07/8/15 - 09:48 am
Clovis Oncology
rucaparib
cancer
Clovis Wins One ASCO '15 Battle, Loses Another, Against Rival AstraZeneca
TheStreet.com
Mon, 06/1/15 - 09:41 am
Clovis Oncology
ASCO
rucaparib
AstraZeneca
Lynparza
rociletinib
AZD9291
Clovis Oncology’s Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Highly Compelling Clinical Activity
Yahoo
Sat, 05/30/15 - 05:41 pm
Clovis Oncology
ASCO
rucaparib
ovarian cancer
Clovis Jumps After Hours On Accelerated Review Of Ovarian Cancer Drug
Barron's
Mon, 04/6/15 - 06:12 pm
Clovis Oncology
rucaparib
ovarian cancer
Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiat
Yahoo/BusinessWire
Sun, 09/28/14 - 09:39 am
rucaparib
ovarian cancer
Clovis Oncology
3 Biotechs Generating a Lot Of Buzz
Wall St Cheat Sheet
Mon, 01/13/14 - 02:47 pm
Celgene
Arrowhead Research
Clovis Oncology
ARC-520
CO-1686
Lucitanib
rucaparib
Ongoing Phase I Monotherapy Study of Rucaparib in Patients with Solid Tumors Demonstrates Clinical Activity, Establishes Dose and Schedule
Yahoo/BusinessWire
Sun, 09/29/13 - 01:30 pm
Clovis Oncology
ovarian cancer
rucaparib
solid tumors
Clovis Oncology Skyrockets After ASCO Presentations
Seeking Alpha
Tue, 06/4/13 - 12:28 pm
ASCO
Clovis Oncology
CO-1686
rucaparib
Clovis Oncology Shares Almost Double on Cancer Drug Trial
Bloomberg
Mon, 06/3/13 - 12:38 pm
Clovis Oncology
rucaparib
ovarian cancer